| http://www.w3.org/ns/prov#value | - Study Design and Ethics ApprovalThe screening for pregnancy endpoints (SCOPE) study is a prospective, multicentre cohort study with primary aims of developing screening tests to identify women at risk of preeclampsia, small-for-gestational-age (SGA) infants, and spontaneous preterm birth and is registered with the Australia New Zealand Clinical Trial Registry: ACTRN12607000551493.
|
